US FDA GRANTS ORPHAN-DRUG DESIGNATION TO PROMETIC’S PLASMA-DERIVED PLASMINOGEN DRUG

March 14, 2013
Posted by: Prometic Prometic
Posted In: Press Releases, Press Releases 2013
X